Sinotherapeutics Inc. (SHA:688247)
10.25
-0.12 (-1.16%)
Mar 13, 2025, 4:00 PM CST
Sinotherapeutics Company Description
Sinotherapeutics Inc., a specialty pharmaceutical company, develops generic and formulation products in China.
It offers posaconazole delayed-release tablets, ursodeoxycholic acid capsules, bupropion hydrochloride extended-release tablets, paroxetine extended-release tablets, sevelamer carbonate tablets, and propafenone hydrochloride extended-release capsules.
The company provides CRO/CDMO services including pre-formulation study, formulation and process development, clinical sample manufacturing, NDA registration batch manufacturing, quality standard establishment, and regulatory dossier document preparation and submission.
Sinotherapeutics Inc. was founded in 2012 and is headquartered in Shanghai, China.
Sinotherapeutics Inc.
Country | China |
Founded | 2012 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 260 |
Contact Details
Address: Greenland Being Fun Plaza Shanghai, 201210 China | |
Phone | 86 21 6881 9009 |
Website | sinotph.com |
Stock Details
Ticker Symbol | 688247 |
Exchange | Shanghai Stock Exchange |
Fiscal Year | January - December |
Reporting Currency | CNY |
ISIN Number | CNE100005PL9 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Yun Fang Larry | Deputy General Manager |
Kun Li | Deputy General Manager |